On Friday, a prominent specialist described research to The Wall Street Journal showing that the government's treatment plan wouldn't work on fully two-thirds of the 300 patients analyzed at one major Mumbai hospital. The results suggest India's plan is "a futile exercise" that will "serve to amplify resistance [of TB to conventional treatments]," said the researcher, Dr. Zarir Udwadia. "It is morally and medically disastrous."
Shown the findings, Mario Raviglione, director of the World Health Organization's Stop TB Department, called India's approach to treating drug-resistant TB "complete nonsense."
This is a classic instance of bad science creating disastrous results. The important story is here.